786627-71-2 Usage
Description
1-Pyrrolidineaceticacid, alpha-methyl-, (alphaS)-(9CI), also known as L-232,740, is a chemical compound that functions as a selective agonist for the serotonin 5-HT1A receptor. It has been studied for its potential therapeutic effects on the central nervous system, particularly in the treatment of anxiety and depression. L-232,740 has demonstrated promising results in animal models and is being investigated for its potential to improve cognitive function and memory. Further research is needed to fully understand its mechanism of action and potential applications in treating various psychiatric and neurological disorders.
Uses
Used in Pharmaceutical Industry:
1-Pyrrolidineaceticacid, alpha-methyl-, (alphaS)-(9CI) is used as a therapeutic agent for the treatment of anxiety and depression due to its selective agonist activity on the serotonin 5-HT1A receptor. Its potential to improve cognitive function and memory also makes it a candidate for the treatment of various psychiatric and neurological disorders.
Used in Research and Development:
In the field of research and development, 1-Pyrrolidineaceticacid, alpha-methyl-, (alphaS)-(9CI) is utilized for studying the effects of serotonin 5-HT1A receptor agonism on the central nervous system. This helps in understanding the compound's mechanism of action and its potential applications in developing new treatments for psychiatric and neurological disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 786627-71-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,8,6,6,2 and 7 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 786627-71:
(8*7)+(7*8)+(6*6)+(5*6)+(4*2)+(3*7)+(2*7)+(1*1)=222
222 % 10 = 2
So 786627-71-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H13NO2/c1-6(7(9)10)8-4-2-3-5-8/h6H,2-5H2,1H3,(H,9,10)/t6-/m1/s1
786627-71-2Relevant articles and documents
Iodine-mediated direct α-amination of dimethyl methylmalonate using non-protected amines
Itoh, Akichika,Maejima, Saki,Takeda, Mitsumi,Yamaguchi, Eiji
supporting information, (2021/07/21)
In this study, direct C[sbnd]N bond formation was achieved via the reaction of a dimethyl methylmalonate with various amines in the presence of molecular iodine to produce α-aminocarbonyl compounds. This versatile methodology of the α-amination of a carbonyl-containing compound involves the in situ iodination of the dimethyl methylmalonate, thus promoting the formation of its enolate isomer, which then facilitates its nucleophilic substitution reaction with an amine. This strategy is highly practical and can be used in industry due to its requirement of only readily available reagents without any pre-preparation of the amines and other substrates.
1,2-NAPHTHOQUINONE DERIVATIVE AND METHOD FOR PREPARING SAME
-
Paragraph 0330; 0332, (2016/11/21)
Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1to R6, X1 to X4, and n are the same as defined in Claim 1.
